Akebia Ther
AKBA
$0.70-0.93%
End of day · as of Oct 16, 2026, 7:16 AM ET
Mkt cap
$260.13M
EV/Sales
0.52
P/E ratio
N/A
FY2025 Revenue
$236.20M
EPS (TTM)
$-0.11
Gross Margin (FY2025)
83.29%
Profit Margin (FY2025)
-2.26%
Beta
0.35
Div yield
N/A
Sector
Healthcare
Akebia Ther (AKBA) is a drug manufacturers - specialty & generic company listed on US.
Latest reported AKBA revenue for 2025-12-31 was $236.2M. Net income was -$5.3M. Revenue was up 47.5% from 2024-12-31 to 2025-12-31. AKBA currently screens at market cap $260.1M.
Use this AKBA research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full AKBA income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
Akebia Ther (AKBA) is a drug manufacturers - specialty & generic company in the Healthcare sector.
Latest cached Akebia Ther (AKBA) revenue for Dec 31, 2025 was $236.2M. Net income was -$5.3M. Statements: https://lician.com/financials/akba
Akebia Ther (AKBA) market capitalization is $260.1M on the latest cached snapshot.
Akebia Ther (AKBA) cached previous close $0.70; day range $0.69 – $0.70; volume 8,850,205. Session quote: https://lician.com/quote/akba
Akebia Ther (AKBA) latest cached earnings event is "AKBA earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached AKBA filing is 8-K · Oct 14, 2026. Filings: https://lician.com/sec/akba